Brief: Chordate Medical Q4 Loss After Tax Widens To SEK 7.2 Mln

Chordate Medical Holding AB (publ)

25/02/2022 08:11

Feb 25 (Reuters) - Chordate Medical Holding publ AB
 CMHM.ST :
    * INTERIM REPORT CHORDATE MEDICAL HOLDING AB JANUARY -
DECEMBER
2021
    * Q4 NET TURNOVER AMOUNTED TO SEK 403,257 (81,015)
    * Q4 LOSS AFTER TAX WAS SEK -7,191,338 (-5,587,828)
    * OUTLOOK: ONCE AGREEMENT RENEWAL WITH OUR JOINT VENTURE
PARTNER
NANOS MEDICAL WAS FINALIZED, PRODUCT REGISTRATION PROCESS FOR
RHINITIS INDICATION IN CHINA WAS RESTARTED. NANOS MAKES
ASSESSMENT THAT MARKET APPROVAL CAN BE OBTAINED IN 2023.

Source text for Eikon:  ID:nBQN9j1zQ9 
Further company coverage:  CMHM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))